Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus (Q35355811)

7 August 2017

Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus (English)

1 reference

7 August 2017

1 reference

1 reference

6

T Poynard

1 reference

7 August 2017

3

P Cacoub

1 reference

7 August 2017

10

J C Piette

1 reference

7 August 2017

P Cresta

1

1 reference

7 August 2017

L Musset

2

1 reference

7 August 2017

L Frangeul

4

1 reference

7 August 2017

D Vitour

5

1 reference

7 August 2017

P Opolon

7

1 reference

7 August 2017

D T Nguyen

8

1 reference

7 August 2017

F Golliot

9

1 reference

7 August 2017

J M Huraux

11

1 reference

7 August 2017

F Lunel

12

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

7 August 2017

1 reference

7 August 2017

45

1 reference

7 August 2017

1

1 reference

7 August 2017

122-128

1 reference

Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Biologic and clinical significance of cryoglobulins. A report of 86 cases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Hepatitis C virus in patients with cryoglobulinemia type II.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Characterization of cryoglobulins by immunoblotting

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

A role for hepatitis C virus infection in type II cryoglobulinemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727565

Liver involvement in the syndrome of mixed cryoglobulinemia

26 September 2018

1 reference

12 December 2020

[Association of cryoglobulins and hepatic disease: incidence, nature and immunochemical characteristics of cryoglobulinemia]

1 reference

12 December 2020

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

12 December 2020

Treatment of idiopathic mixed cryoglobulinemia with alpha interferon

1 reference

12 December 2020

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

1 reference

12 December 2020

Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.45.1.122

1 reference

7 August 2017

1 reference

7 August 2017

1 reference